home / stock / acrs / acrs short
Short Information | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,472,961 |
Total Actual Volume | 14,992,554 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 123,648 |
Average Short Percentage | 17.01% |
Is there a ACRS Short Squeeze or Breakout about to happen?
See the ACRS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-13-2025 | $1.5 | $1.47 | $1.55 | $1.47 | 467,122 | 55,348 | 11.85% |
06-12-2025 | $1.57 | $1.53 | $1.57 | $1.515 | 420,505 | 52,247 | 12.42% |
06-11-2025 | $1.53 | $1.57 | $1.59 | $1.4838 | 846,581 | 162,109 | 19.15% |
06-10-2025 | $1.5 | $1.51 | $1.55 | $1.45 | 299,379 | 39,632 | 13.24% |
06-09-2025 | $1.55 | $1.49 | $1.55 | $1.465 | 786,932 | 112,728 | 14.32% |
06-06-2025 | $1.55 | $1.53 | $1.645 | $1.53 | 737,323 | 149,069 | 20.22% |
06-05-2025 | $1.63 | $1.56 | $1.63 | $1.535 | 637,246 | 97,375 | 15.28% |
06-04-2025 | $1.48 | $1.61 | $1.6499 | $1.47 | 1,689,307 | 239,036 | 14.15% |
06-03-2025 | $1.45 | $1.47 | $1.51 | $1.4195 | 427,751 | 89,966 | 21.03% |
06-02-2025 | $1.47 | $1.44 | $1.5301 | $1.42 | 646,039 | 134,717 | 20.85% |
05-30-2025 | $1.45 | $1.46 | $1.475 | $1.39 | 751,245 | 97,986 | 13.04% |
05-29-2025 | $1.44 | $1.46 | $1.46 | $1.38 | 827,345 | 192,471 | 23.26% |
05-28-2025 | $1.36 | $1.41 | $1.56 | $1.35 | 2,811,704 | 385,617 | 13.71% |
05-27-2025 | $1.32 | $1.27 | $1.34 | $1.27 | 623,977 | 70,506 | 11.3% |
05-23-2025 | $1.25 | $1.26 | $1.285 | $1.22 | 404,728 | 64,091 | 15.84% |
05-22-2025 | $1.28 | $1.26 | $1.3111 | $1.25 | 462,233 | 95,134 | 20.58% |
05-21-2025 | $1.35 | $1.29 | $1.38 | $1.27 | 641,660 | 141,595 | 22.07% |
05-20-2025 | $1.3 | $1.35 | $1.3775 | $1.28 | 489,120 | 93,743 | 19.17% |
05-19-2025 | $1.29 | $1.3 | $1.335 | $1.275 | 531,215 | 119,593 | 22.51% |
05-16-2025 | $1.2 | $1.31 | $1.32 | $1.18 | 491,142 | 79,998 | 16.29% |
News, Short Squeeze, Breakout and More Instantly...
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
1.96% G/L:
$1.47 Last:
467,122 Volume:
$1.50 Open:
$1.47 Close:
Aclaris Therapeutics Inc. Website:
- Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time, and Affinity to Thymic Stromal Lymphopoietin (TSLP) - - Top Line Results Expected in the Second Half of 2026 - WAYNE, Pa., June 02, 2025 (GLOBE NEWSWIRE) ...
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferen...
WAYNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that Aclaris’ Chief Executive Officer Neal Walker and other me...